About Us
Marcio Scorsin
MD, PhD,, cardiac surgeon specialized in mitral valve surgery
CMO & co-founder Epygon, specialized in transcathetermitral valve bioprosthesis
CMO and Co-founder of Myosixsold to Genzyme/Sanofi in 2002
Eric Halioua
Serial entrepreneur, co-founder of 5 biotechnology and medical devices company. Raised more than 100 million over the course of his career and has had numerous successes in the sale and initial public offering of biotechnology companies. CEO and co-founder of Myosixsold to Genzyme/Sanofi in 2002
ErgoSuture
ErgoSuture is a medical technology research boutique driving surgical innovation through advanced suturing systems. Our tailor-made solutions are designed by surgeons for surgeons, to help improve care and increase access to care.
Focused on engaging strategic partners to co-develop or commercialize our innovations, as well as optimize future research and development for the surgical community.
Our History
ValSculp was co-founded by Dr.MarcioScorsin, an experienced cardiac surgeon and serial entrepreneur who specializes in mitral valve repair & replacement.
What started as a search for a suturing system that could be mounted to a transcatheter system eventually led him to a partnership with ErgoSuture - which would later evolve into the development of SATAR.
ValSculp: Key Facts
ValSculpis a biotechnology solutions provider focused on mitral valve regurgitation, a condition that impacts millions of people yet has few viable treatment options outside of risky and/or ineffective procedures.
Our new proprietary transcatheter technology aims to replicate the benefits of status quo options while mitigating risk and other pain points. It takes the shape of an adjustable ring, anchored by minimally-invasive sutures, that can conform to any patient’s anatomy.
Our Vision
To develop suture-based solutions applied via transcatheter route to repair intra-cardiac pathologies.